Pilot study of feasibility and safety of personalized autologous CD8+ T cell therapy plus anti-PD-1 antibody in advanced gastrointestingal malignancies - Stand Up To Cancer

Blog

Posted October 14, 2019

Pilot study of feasibility and safety of personalized autologous CD8+ T cell therapy plus anti-PD-1 antibody in advanced gastrointestingal malignancies

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.